Blood Pressure and Albuminuria Reduction with Lorundrostat in Chronic Kidney Disease Stages 1 to 3 in the Launch-HTN trial Liffert Vogt, MD, PhD, Professor of Nephrology and Renal Transplantation at ...
Pfizer Inc. (NYSE: PFE) will present data from more than 50 company-sponsored, investigator-sponsored and collaborative research abstracts across its infectious disease pipeline and portfolio at the ...
October 20, 2026 expert reaction to press release from the Menopause Society about testosterone therapy and cardiovascular disease in postmenopausal women, about a presentation to ...
Pfizer Inc. (NYSE: PFE) will present data from more than 50 company-sponsored, investigator-sponsored and collaborative research abstracts across its ...
All accepted abstracts will be published in the online supplement of the Multiple Sclerosis Journal and made available through the MSToronto2026 website, event app, and digital platform. Additionally, ...
A decade-long Henry Ford Health study found that 72 percent of emergency department visits for hidradenitis suppurativa led to hospital admission, and that patients who established outpatient ...
Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced that new clinical, biomarker, and ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Latus Bio, Inc. (Latus), a biotechnology company engineering gene therapies at scale, today announced the presentation of novel engineered AAV capsids with significantly enhanced kidney tropism at the ...
— Late-breaking oral presentation of first-in-human data (LBA-11) showed that a single intravenous infusion of IASO206 generated functional BCMA CAR-T cells in vivo without lymphodepleting ...
Jennifer Simonson is a business journalist with a decade of experience covering entrepreneurship and small business. Drawing on her background as a founder of multiple startups, she writes for Forbes ...
Background:Early death from female breast cancer is influenced by disease biology and factors such as age, marginalization, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results